Valproate-induced hyperammonemic encephalopathy;Encéphalopathie hyperammoniémique au valproate de sodium

Revue de Medecine Interne

Volumn 32, Issue 6, 2011, Pages

  Granel, B ^a   Gavaret, M ^b   Le Baut, X ^a   Sautereau, N ^a   Rodriguez, D ^a   Rossi, P ^a   Bagneres D ^a   Demoux, A L ^a   Frances Y ^a  

^a HÔPITAL NORD   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

Adverse effect; Encephalopathy; Hyperammonemia; Valproate

Indexed keywords

AMMONIA; GABAPENTIN; VALPROIC ACID;

ADULT; ALCOHOL LIVER CIRRHOSIS; AMMONIA BLOOD LEVEL; ARTICLE; BRAIN DISEASE; CASE REPORT; CONSCIOUSNESS; CONVALESCENCE; DROWSINESS; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMAN; HYPERAMMONEMIA; HYPERAMMONEMIC ENCEPHALOPATHY; MALE; MEDICAL HISTORY; PHYSICAL EXAMINATION; SLOW BRAIN WAVE;

ADULT; ANTICONVULSANTS; HUMANS; HYPERAMMONEMIA; MALE; NEUROTOXICITY SYNDROMES; VALPROIC ACID;

EID: 79956061253     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2010.06.010     Document Type: Article

References (18)

1. Marescaux C., Warter J.M., Micheletti G., Rumbach L., Coquillat G., Kurtz D. Stuporous episodes during treatment with sodium valproate: report of seven cases. Epilepsia 1982, 23:297-305.
2. Marescaux C., Warter J.M., Laroye M., Rumbach L., Micheletti G., Koehl C., et al. Le valproate de sodium: une drogue hyperammoniémiante. Étude chez l'épileptique et chez le volontaire sain. J Neurol Sci 1983, 58:195-209.
3. Ratnaike R.N., Schapel G.J., Purdie G., Rischbieth R.H., Hoffmann S. Hyperammonaemia and hepatotoxicity during chronic valproate therapy: enhancement by combination with other antiepileptic drugs. Br J Clin Pharmacol 1986, 22:100-103.
4. Duarte J., Macias S., Coria F., Fernandez E., Clavería L.E. Valproate-induced coma: case report and literature review. Ann Pharmacother 1993, 27:582-583.
5. Stephens J.R., Levy R.H. Effects of valproate and citrulline on ammonium-induced encephalopathy. Epilepsia 1994, 35:164-171.
6. Blindauer K.A., Harrington G., Morris G.L., Ho K.C. Fulminant progression of demyelinating disease after valproate-induced encephalopathy. Neurology 1998, 51:292-295.
7. Kifune A., Kubota F., Shibata N., Akata T., Kikuchi S. Valproic acid-induced hyperammonemic encephalopathy with triphasic waves. Epilepsia 2000, 41:909-912.
8. Verrotti A., Trotta D., Morgese G., Chiarelli F. Valproate-induced hyperammonemic encephalopathy. Metab Brain Dis 2002, 17:367-373.
9. Ziyeh S., Thiel T., Spreer J., Klisch J., Schumacher M. Valproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy. Epilepsia 2002, 43:1101-1105.
10. Tanaka A., Wada T., Maruyama M., Tanaka A., Takikawa H., Komatsu Y. Hyperammonemia-induced encephalopathy due to ornithine transcarbamylase deficiency in an adult woman: identification of novel missense mutations. J Gastroenterol 2005, 40:106-107.
11. Ricard C., Martin K., Tournier M., Bégaud B., Verdoux H. Troubles cognitifs, syndrome extrapyramidal et hyperammoniémie sous traitement thymorégulateur par divalproate de sodium: à propos d'un cas. Encephale 2005, 31:98-101.
12. Beyenburg S., Back C., Diederich N., Lewis M., Reuber M. Is valproate encephalopathy under-recognised in older people? A case series. Age Ageing 2007, 36:344-346.
13. Alqahtani S., Federico P., Myers R.P. A case of valproate-induced hyperammonemic encephalopathy: look beyond the liver. CMAJ 2007, 177:568-569.
14. Dealberto M.J., Sarazin F.F. Valproate-induced hyperammonemic encephalopathy without cognitive sequelae: a case report in the psychiatric setting. J Neuropsychiatry Clin Neurosci 2008, 20:369-371.
15. Subhash H.S., Heddle R.J., Schultz D.W., Ring J., Thompson C.H. Hepatic encephalopathy precipitated by sodium valproate therapy. Med J Aust 2008, 188:549.
16. Segura-Bruna N., Rodriguez-Campello A., Puente V., Roquer J. Valproate-induced hyperammonemic encephalopathy. Acta Neurol Scand 2006, 114:1-7.
17. Bauer G., Bauer R. EEG, drugs effects and central nervous system poisoning. Chapter 34. Electroencephalography. Basic principles, clinical applications, and related fields, Niedermeyer 2005, 701-723. Lippincott Williams & Wilkins. Fifth edition. F. Lopes da Silva (Ed.).
18. Sechi G., Murgiaa B., Saua G., Peddonea L., Tirottob A., Barrocu M., et al. Asterixis and toxic encephalopathy induced by gabapentin. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:195-199.